N
NewAmsterdam Pharma Company NV
F:KH6
NewAmsterdam Pharma Company NV
F:KH6
Price:
25
EUR
3.31%
Market Closed
Market Cap:
€119.6B
Balance Sheet
Balance Sheet Decomposition
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Balance Sheet Decomposition is not available for
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Balance Sheet
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Currency: EUR
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
1
|
1
|
439
|
|
| Cash |
1
|
1
|
0
|
|
| Cash Equivalents |
0
|
0
|
439
|
|
| Total Receivables |
0
|
0
|
2
|
|
| Other Current Assets |
1
|
0
|
8
|
|
| Total Current Assets |
2
|
1
|
448
|
|
| PP&E Net |
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
83
|
|
| Note Receivable |
0
|
0
|
0
|
|
| Long-Term Investments |
138
|
138
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
140
N/A
|
140
0%
|
532
+281%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
11
|
|
| Accrued Liabilities |
0
|
0
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
19
|
|
| Total Current Liabilities |
0
|
0
|
35
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
12
|
8
|
12
|
|
| Total Liabilities |
12
N/A
|
8
-37%
|
47
+498%
|
|
| Equity | ||||
| Common Stock |
138
|
138
|
599
|
|
| Retained Earnings |
11
|
6
|
115
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
|
| Total Equity |
127
N/A
|
132
+3%
|
485
+268%
|
|
| Total Liabilities & Equity |
140
N/A
|
140
0%
|
532
+281%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
18
|
18
|
82
|
|
Switch to:
Switch to:
See Also
Discover More
